Lixte Biotechnology Holdings Inc. share price logo

Lixte Biotechnology Holdings Inc.

NASDAQ: LIXT

Small Cap

$7.38

-0.24

(-3.09%)

Live

as on

Lixte Biotechnology Holdings Inc. Stock Performance

as on June 23, 2026 at 3:11 am IST

  • Day's Low

    Day's High

    $7.17
    $7.76
    downward going graph

    2.85%

    Downside

    5.15%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.68
    $7.78
    downward going graph

    90.83%

    Downside

    5.42%

    Upside

    downward going graph

Lixte Biotechnology Holdings Inc. share price movements today

Previous Close
$7.61
Open
$7.50
Volume
375.1K
Day's Low - High
$7.17 - $7.76
52 Week Low - High
$0.68 - $7.78

Lixte Biotechnology Holdings Inc. Historical Returns

1 Month Return
+ 29.42 %
3 Month Return
+ 177.74 %
1 Year Return
+ 875.64 %
3 Year Return
+ 43.23 %
5 Year Return
-73.67 %

Lixte Biotechnology Holdings Inc. Stock Fundamentals & Key Indicators

Check Lixte Biotechnology Holdings Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$132.3M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-101.95%

Lixte Biotechnology Holdings Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lixte Biotechnology Holdings Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Lixte Biotechnology Holdings Inc. image
Lixte Biotechnology Holdings Inc.
NA$132.3M-73.67%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.1B60.79%69.8712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$114.6B139.12%26.835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.9B14.22%14.8829.65%0.59%

Stock Returns calculator for Lixte Biotechnology Holdings Inc. Stock including INR - Dollar returns

The Lixte Biotechnology Holdings Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Lixte Biotechnology Holdings Inc. investment value today

Current value as on today

₹10,34,671

Returns

₹9,34,671

(+934.67%)

Returns from Lixte Biotechnology Holdings Inc. Stock

₹8,46,154 (+846.15%)

Dollar Impact

₹88,518 (+88.52%)

Indian Investors' Interest in Lixte Biotechnology Holdings Inc. Stock

Search interest for Lixte Biotechnology Holdings Inc. Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:36% versus previous 30 day period

Lixte Biotechnology Holdings Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-1
0
-1
0
0
0
0
-1
-1
-1
EBITDA
0
0
-1
0
0
0
0
-2
-2
-1
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
0
-1
0
0
0
0
-2
-2
-1
Income Tax Expense
0
0
-
0
0
-
-
-
-
-
Net Income
-1
0
-1
0
0
0
0
-2
-2
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Lixte Biotechnology Holdings Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-2
-1
-2
-2
-3
-6
-6
-5
-3
-5
EBITDA
-2
-1
-2
-2
-3
-6
-6
-5
-3
-6
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-2
-1
-2
-2
-3
-6
-6
-5
-3
-6
Income Tax Expense
0
0
0
0
0
0
0
0
-
-
Net Income
-2
-1
-2
-2
-3
-6
-6
-5
-3
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Lixte Biotechnology Holdings Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
-1
0
0
0
0
-1
-2
-1
Operating Cash Flow
0
0
0
0
0
0
0
-1
-1
Investing Cash Flow
-
-
-
-
0
-
-2
0
0
Financing Cash Flow
-
-
-
-
0
0
5
3
-
Change in Cash
0
0
0
0
0
0
2
2
-1

Lixte Biotechnology Holdings Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-2
-2
-3
-6
-6
-5
-3
-6
Operating Cash Flow
-1
-1
-1
-2
-4
-4
-4
-3
-3
Investing Cash Flow
-
-
-
-
-
5
-
-
-3
Financing Cash Flow
2
4
4
4
3
5
3
-
10
Change in Cash
1
2
-1
2
0
0
-1
-3
4

Global Institutional Holdings in Lixte Biotechnology Holdings Inc.

Funds
Holdings
Ethos Financial Group LLC
0.21%
CLEAR STREET LLC.
0%
Atlas Legacy Advisors, LLC
0.12%
Tower Research Capital LLC
0.01%
Axxcess Wealth Management, LLC
0%
See all

Insights on Lixte Biotechnology Holdings Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, LIXT stock has moved up by 875.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LIXT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LIXT has outperformed top 5 stocks with highest market-cap in its industry

About Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Boca Raton, Florida.
OrganisationLixte Biotechnology Holdings Inc.
Headquarters433 Plaza Real, Boca Raton, FL, United States, 33432
IndustryBiotechnology
CEOMr. Geordan G. Pursglove
E-voting on sharesClick here to vote

Key Management of Lixte Biotechnology Holdings Inc.

Name

Title

Mr. Geordan G. Pursglove

CEO, President & Chairman

Mr. Peter M. Stazzone

Chief Financial Officer

Mr. Bastiaan van der Baan M.Sc.

Chief Scientific Officer

FAQs

What is Lixte Biotechnology Holdings Inc. share price today?

Lixte Biotechnology Holdings Inc. share price today is $7.38 as on . Lixte Biotechnology Holdings Inc. share today touched a day high of $7.76 and a low of $7.17.

What is the 52 week high and 52 week low for Lixte Biotechnology Holdings Inc. share?

Lixte Biotechnology Holdings Inc. share touched a 52 week high of $7.78 on and a 52 week low of $0.68 on . Lixte Biotechnology Holdings Inc. stock price today i.e. is trending at $7.38,which is 5.14% down from its 52 week high and 990.10% up from its 52 week low.

What is Lixte Biotechnology Holdings Inc.'s market capitalisation today?

Lixte Biotechnology Holdings Inc. market capitalisation is $0.00T as on .

How to invest in Lixte Biotechnology Holdings Inc. Stock (LIXT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lixte Biotechnology Holdings Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lixte Biotechnology Holdings Inc. Shares that will get you 0.2033 shares as per Lixte Biotechnology Holdings Inc. share price of $7.38 per share as on June 22, 2026 at 9:41 pm IST.

What is the minimum amount required to buy Lixte Biotechnology Holdings Inc. Stock (LIXT) from India?

Indian investors can start investing in Lixte Biotechnology Holdings Inc. (LIXT) shares with as little as ₹94.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.80 in Lixte Biotechnology Holdings Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Lixte Biotechnology Holdings Inc. share’s latest price of $7.38 as on June 22, 2026 at 9:41 pm IST, you will get 1.3550 shares of Lixte Biotechnology Holdings Inc.. Learn more about fractional shares .

What are the returns that Lixte Biotechnology Holdings Inc. has given to Indian investors in the last 5 years?

Lixte Biotechnology Holdings Inc. stock has given -73.67% share price returns and 26.88% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?